Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
COMMENTARY
Drug Repositioning May Promise Greater Chance of Success, but Problems Remain
Government, industry and academia are beginning to tackle “drug repositioning (DR),” also known as “drug repurposing,” in earnest. DR is the application of known drugs and compounds to new indications (diseases) they were not originally developed for. Among Japanese drug…
To read the full story
COMMENTARY
- Supply Woes Plague All 7 New Biosimilar Ingredients Listed since 2023
November 16, 2026
- Japan Drug Wholesalers Caught in Multiple Dilemmas as Price Gap Narrows
November 10, 2026
- Deeper CEA Price Cuts Demand More Than a “Certain Degree of Validity”
November 2, 2026
- Alzheimer’s Pipeline Looks Past Amyloid to Earlier Intervention, Tau Targets
October 28, 2026
- Lp(a) Drugs Face Next Test in Quest to Cut Cardiovascular Risk
October 19, 2026





